demonstrated activity in non-muscle invasive bladder cancer, including complete responses in four of five patients with low-grade disease who received the virus-like drug conjugate with light ...

A healthy diet in prostate cancer patients on active surveillance was ... demonstrated activity in non-muscle invasive ...

Moreover, bladder cancer is the most expensive cancer to treat per patient. A definitive cure for bladder cancer therefore would have wide-ranging positive impacts.

Barcelona, Spain: Patients with advanced bladder cancer that had spread to other parts of the body (metastasised) have responded well in a phase I clinical trial of an investigational drug ...

The survival time for patients with advanced small cell bladder cancer is only about 7 to 13 months and only 7 to 9 months for patients with small cell/neuroendocrine prostate cancer. The early ...